NEXGEL, INC. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
NEXGEL, INC. (NXGL) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $119.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-17
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $119.00K.
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-09-30 was $67.00K, a 21.82% increase year-over-year.
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2023-06-30 was $29.00K, a 46.30% decline year-over-year.
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2022-09-30 was $55.00K, a 129.17% increase year-over-year.
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2022 was $231.00K, a 3.59% increase from fiscal 2021.
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2021 was $223.00K, a 3.88% decline from fiscal 2020.
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2020 was $232.00K, a 5700.00% increase from fiscal 2019.
- NEXGEL, INC. apic, share-based payment arrangement, increase for cost recognition for fiscal 2019 was $4.00K.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $119.00K 10-Q · filed 2026-08-17 | |||
| 2023-09-30 | $67.00K 10-Q · filed 2023-11-13 | $96.00K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2023-06-30 | $29.00K 10-Q · filed 2023-11-13 | |||
| 2022-12-31 | $231.00K 10-K · filed 2023-03-28 | |||
| 2022-09-30 | $55.00K 10-Q · filed 2023-11-13 | $109.00K derived: sum of 2 quarters · filed 2023-11-13 | $164.00K derived: sum of 3 quarters · filed 2023-11-13 | |
| 2022-06-30 | $54.00K 10-Q · filed 2023-11-13 | $109.00K derived: sum of 2 quarters · filed 2023-11-13 | ||
| 2022-03-31 | $55.00K 10-Q · filed 2023-11-13 | |||
| 2021-12-31 | $223.00K 10-K · filed 2023-03-28 | |||
| 2021-09-30 | $24.00K 10-Q · filed 2022-11-08 | $98.00K derived: sum of 2 quarters · filed 2022-11-08 | $167.00K derived: sum of 3 quarters · filed 2022-11-08 | |
| 2021-06-30 | $74.00K 10-Q · filed 2022-11-08 | $143.00K derived: sum of 2 quarters · filed 2022-11-08 | ||
| 2021-03-31 | $69.00K 10-Q · filed 2022-11-08 | |||
| 2020-12-31 | $232.00K 10-K · filed 2022-03-21 | |||
| 2020-09-30 | $83.00K 10-Q · filed 2021-11-10 | $123.00K derived: sum of 2 quarters · filed 2021-11-10 | $187.00K derived: sum of 3 quarters · filed 2021-11-10 | |
| 2020-06-30 | $40.00K 10-Q · filed 2021-11-10 | $104.00K derived: sum of 2 quarters · filed 2021-11-10 | ||
| 2020-03-31 | $64.00K 10-Q · filed 2021-11-10 | |||
| 2019-12-31 | $4.00K 10-K · filed 2021-03-31 | |||
| 2019-09-30 | $3.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |